Home/Filings/4/0001209191-19-013908
4//SEC Filing

Daly Timothy 4

Accession 0001209191-19-013908

CIK 0001636651other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 9:54 PM ET

Size

5.5 KB

Accession

0001209191-19-013908

Insider Transaction Report

Form 4
Period: 2019-02-24
Daly Timothy
VP, Finance & Corp. Controller
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-02-24+50,00050,000 total
    Exercise: $1.89Exp: 2029-02-23Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001535896

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:54 PM ET
Size
5.5 KB